Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Inventory (2016 - 2025)

Historic Inventory for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $2.7 billion.

  • Bristol Myers Squibb's Inventory rose 520.14% to $2.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year increase of 520.14%. This contributed to the annual value of $2.7 billion for FY2025, which is 520.14% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Inventory stood at $2.7 billion, which was up 520.14% from $2.8 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Inventory's 5-year high stood at $3.3 billion during Q3 2024, with a 5-year trough of $2.0 billion in Q1 2021.
  • In the last 5 years, Bristol Myers Squibb's Inventory had a median value of $2.5 billion in 2023 and averaged $2.5 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Inventory plummeted by 3113.54% in 2021, and later surged by 3678.16% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Inventory (Quarter) stood at $2.1 billion in 2021, then rose by 11.65% to $2.3 billion in 2022, then grew by 13.81% to $2.7 billion in 2023, then decreased by 3.94% to $2.6 billion in 2024, then increased by 5.2% to $2.7 billion in 2025.
  • Its Inventory was $2.7 billion in Q4 2025, compared to $2.8 billion in Q3 2025 and $2.7 billion in Q2 2025.